跳至主要内容
临床试验/JPRN-UMIN000040783
JPRN-UMIN000040783招募中未知

Effect of a novel carbonate apatite in combination with fibroblast growth factor (FGF)-2 on periodontal regeneration - Effect of FGF-2 and carbonateapatite on periodontal regeneration

Tokyo Dental College0 个研究点目标入组 66 人开始时间: 2020年9月1日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
66

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients with uncontrolled systemic diseases, those with allergic reactions to FGF-2, Bio-Oss, or Cytrans those with (or had) oral malignant tumor, in pregnancy or nursing, those receiving anti-coagulant drugs or any other drugs that may influence the clinical results.

研究者

相似试验

已完成
Unknown
Comparative study of apatite carbonate and octacalcium phosphate in sinus liftsmissing tooth
JPRN-UMIN000052547Kanagawa Dental University50
招募中
Unknown
Differences in pain between different sealing materials (sealers) used at the end of root canal therapyDiseases of the digestive system
KCT0008770Yonsei University Health System, Dental Hospital180
已完成
1 期
The Effect of Root Canal Sealer on Postoperative PaiPostoperative pain arising after root canal treatment is undesirable but may manifest in hours and may persist for days following treatment. The incidence of post-endodontic pain has been reported to be between 3-58% with severe pain being observed at a rate of less than 12% of the entire population after treatmentcalcium silicate-based root canal sealer,calcium hydroxide-based root canal sealer,postoperative painroot canal treatment
TCTR20221118004/A80
进行中(未招募)
不适用
Evaluation of Calcium Acetate/Magnesium Carbonate (OsvaRen®) compared to Sevelamer (Renagel®) in Haemodialysis PatientsElevated serum phosphate levels (hyperphosphataemia) in patients with chronic renal failure on dialysis (haemodialysis, peritoneal dialysis)MedDRA version: 9.1Level: LLTClassification code 10020711Term: Hyperphosphataemia
EUCTR2006-002589-20-PTFresenius Medical Care Deutschland GmbH248
进行中(未招募)
不适用
Evaluation of Calcium Acetate/Magnesium Carbonate (OsvaRen®) compared to Sevelamer (Renagel®) in Haemodialysis PatientsElevated serum phosphate levels (hyperphosphataemia) in patients with chronic renal failure on dialysis (haemodialysis, peritoneal dialysis)MedDRA version: 9.1Level: LLTClassification code 10020711Term: Hyperphosphataemia
EUCTR2006-002589-20-DEFresenius Medical Care Deutschland GmbH248